ArticleOpen forum infectious diseases2026
Major Depressive Episodes and Psychiatric Symptoms Among HIV Controllers Compared With Antiretroviral-Treated People Living With HIV.
Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Major depressive episodes are highly prevalent among people living with HIV (PWH), despite sustained virological suppression. However, psychiatric outcomes among HIV controllers (HIC), who maintain long-term spontaneous control of viral replication without antiretroviral therapy (ART), remain poorly characterized. We assessed major depressive episodes and psychiatric symptom profiles among HIC compared with ART-treated PWH and explored associated factors. Methods: In this prospective observational study, HIC from the French multicenter ANRS CO21 CODEX cohort were compared with PWH receiving suppressive ART. Major depressive episodes were assessed using the Mini-International Neuropsychiatric Interview (M.I.N.I.), and psychiatric symptoms were evaluated using the Symptom Checklist-90-Revised. Between-group comparisons and univariable analyses were performed to identify factors associated with psychiatric outcomes. Results: Ninety-eight participants were included (57 HIC and 41 ART-treated PWH). The prevalence of lifetime major depressive episodes was high in both groups and did not differ between HIC and ART-treated participants (35% vs 41%). Most psychiatric symptom dimensions were comparable between groups, although HIC showed higher interpersonal sensitivity and psychopathology composite scores on the SCL-90-R, reflecting higher psychological distress. In both groups, psychiatric outcomes were associated with preexisting psychiatric history, alcohol use, and sociodemographic factors, but not with immunovirological parameters. Conclusions: Despite spontaneous viral control, HIC do not exhibit more favorable psychiatric outcomes than ART-treated PWH. The high prevalence of depressive disorders appears to be primarily driven by behavioral and sociodemographic factors and preexisting psychiatric conditions rather than immunovirological status, supporting routine psychiatric assessment in HIV care, including for HIC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.